Navigation Links
Robin C. Stracey Joins Cantimer, Inc. as President and CEO
Date:12/17/2007

Co-founder Ray Stewart, Ph.D., continues as Chief Technology Officer

MENLO PARK, Calif., Dec. 17 /PRNewswire/ -- Cantimer, Inc., a privately-held development stage company commercializing a patented, proprietary sensor technology platform having applications in life science, health care, bio-defense and consumer markets announced today that Robin C. Stracey has joined the company as President and Chief Executive Officer, effective December 17, 2007. He has also been appointed to the Company's Board of Directors.

Mr. Stracey succeeds Cantimer co-founder Ray Stewart, Ph.D., who will continue to serve as Chief Technology Officer and as a member of the Board of Directors. "Ray has done an exceptional job in developing Cantimer's technology platform and in guiding the company through its early stages," commented A. Wayne Tamarelli, Ph.D., an early investor in Cantimer and a member of its Board of Directors. "He will continue to play the leading technical role as we further develop the platform and explore its application to a number of potentially large opportunities for the rapid detection and measurement of analytes of interest."

"We are delighted to have Robin join us to lead the next phase of the Company's growth as his background and skills are directly aligned with the Company's needs," noted Ray Stewart, Ph.D. "His experience in building and leading successful life science and diagnostics businesses will be invaluable as we move towards the launch of our first commercial product- a non-invasive, point-of-care device for rapid, convenient measurement of human hydration status," added Stewart.

Before joining Cantimer, Mr. Stracey served as Director, President and CEO of Applied Imaging Corporation, a publicly-traded, specialty medical device company focused on the early diagnosis of genetic disorders and cancer. Robin negotiated the successful sale of Applied Imaging to the UK-based Genetix Group plc. in 2006. Prior to that, he was Vice President and General Manager of an analytical instrument business unit at Thermo Electron Corporation. He joined Thermo Electron from Dade Behring Inc., where he was a Corporate Vice President with general management responsibility for Syva Company, a leading supplier of specialized diagnostic systems and reagents. His early career included a variety of sales, commercial marketing and strategy development positions of increasing responsibility in DuPont's Medical Products Department. Mr. Stracey has a Bachelor of Science degree with honors from the University of Nottingham in the United Kingdom and is a graduate of the Executive Program at the Stanford University Graduate School of Business.

"I am very excited about Cantimer's prospects," noted Stracey. "The Company's technology is elegant and has broad potential application in a number of large markets where accurate, rapid detection and measurement of analytes is important. The initial focus on hydration measurement will create a new and much needed capability within health care," he added.

About Cantimer

Cantimer is a privately-held development stage company commercializing a patented, proprietary sensor technology platform having applications in life science, health care, bio-defense and consumer markets. The technology will initially be embodied into point-of-care products for convenient, non-invasive, measurement and monitoring of human hydration status using saliva as a sample.


'/>"/>
SOURCE Cantimer, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
2. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
3. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
4. Hank Plain Joins Morgenthaler Ventures as Partner
5. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
6. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
7. Dan Broderick Joins Prolog Ventures as Partner
8. Ingenuity Systems Joins Biomarkers Consortium
9. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
10. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
11. Progeniq Joins Microsoft in Bio IT Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Vortex Biosciences , provider of ... of prostate circulating tumor cells using Vortex microfluidic technology ” in Nature Precision Oncology ... with Dr. Dino Di Carlo and Dr. Matthew Rettig at the University of California, ...
(Date:5/23/2017)... ... May 23, 2017 , ... Customers ... their control technology again and again. METTLER TOLEDO has released two new videos ... videos illustrate how integration of the ACT350 into Siemens and Allen Bradley PLCs ...
(Date:5/21/2017)... , ... May 20, 2017 , ... ... helps avoid the lengthy trial and error process by finding the right antidepressant ... can also strengthen the doctor-patient relationship through a personalized approach to treatment. ...
(Date:5/18/2017)... ... ... Clinical Supplies Management (“CSM”), a Great Point Partners II (“GPP”) portfolio company, today ... doubled in size over the past six months with the acquisition of businesses in ... CSM as Chief Financial Officer. Roger has over 25 years of experience in ...
Breaking Biology Technology:
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at http://www.nxt-id.com  under ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
Breaking Biology News(10 mins):